Andrew James Rutter

Title: Andrew James Rutter: Innovator in Oligonucleotide Binding Processes

Introduction

Andrew James Rutter is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of molecular biology, particularly in the monitoring of oligonucleotide binding processes. His innovative approach utilizes chemiluminescence quenching to enhance the understanding of nucleic acid interactions.

Latest Patents

Rutter holds a patent for "Monitoring oligonucleotide binding processes using chemiluminescence quenching." This patent describes a method where an oligonucleotide probe is labeled with a chemiluminescent label at one end and a quencher molecule at the other. The conformation of the probe changes based on its hybridization with a complementary nucleic acid sequence. In the non-hybridized state, the proximity of the chemiluminescent label to the quencher significantly attenuates the emission. Conversely, in the hybridized state, the separation reduces attenuation, allowing for effective monitoring of binding processes.

Career Highlights

Throughout his career, Andrew James Rutter has worked with prominent companies such as Gen-Probe, Inc. and Gen-Probe Cardiff Ltd. His experience in these organizations has contributed to his expertise in the field of oligonucleotide research and development.

Collaborations

Rutter has collaborated with notable colleagues, including Zhaoqiang Li and Keith Smith. These partnerships have furthered advancements in the understanding of oligonucleotide binding and its applications.

Conclusion

Andrew James Rutter's innovative work in monitoring oligonucleotide binding processes has made a significant impact in molecular biology. His contributions continue to influence research and development in this vital area of science.